• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

EE498 Cost of Follow-Up After an Ischemic Cerebrovascular Event in Patients With Atherosclerotic Cardiovascular Disease in Spain: Results from the Reality Study
Ischemic cerebrovascular events stroke and transient ischemic attack (TIA) are a cause of morbidity and mortality in developed countries and entails a high resources consumption and costs for health systems. These patients have an increased risk of suffering a new event with the consequent additional resource consumption and an increased follow-up cost.
Source: Value in Health - December 1, 2022 Category: International Medicine & Public Health Authors: M Castellanos, JM Games, JM Mostaza, I Egocheaga, J Gomez Cerezo, R Campuzano, V Pallares, V Barrios, N Morant Talamante, A Sicras-Mainar, I P érez Román, JM Rodriguez Barrios, FJ Parrondo García, I Martinez Source Type: research

RWD149 Reduction in Ischemic Stroke Rates in Patients With Non-Valvular Atrial Fibrillation During the Period 2013-2020: A Real-Life Study in Spain
The aim of this study is to analyze the variations in the incidence of cardiovascular events and mortality rates in patients with non-valvular atrial fibrillation (NVAF) receiving antithrombotic treatment (VKA, NOAC or antiplatelet drugs) between 2013 and 2020. In addition, this study estimates the impact of these variations in the use of healthcare resources and costs in Spain.
Source: Value in Health - December 1, 2022 Category: International Medicine & Public Health Authors: O Delgado, A Sicras-Mainar, I P érez Román, J Salazar, MI del Campo Alonso, A Echeto, D Vilanova, J Comin-Colet Source Type: research

A Real World Evidence Model To Compare Direct Oral Anticoagulants Safety Outcomes For Atrial Fibrillation Patients In Spain
In the last 10 years, different treatments for stroke prevention in atrial fibrillation (SPAF) have been launched in Spain. However, little is known about clinical outcomes and cost associated to patient events in real world practice. The aim of this model is to assist in the decision making of treatment selection based on the risk of a patient having an event.
Source: Value in Health - October 1, 2017 Category: International Medicine & Public Health Authors: N Mal é, A Solé, N Schoenherr Source Type: research